Initial Experience of Clinical Use of [(99m)Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study

Numerous different molecules of prostate-specific membrane antigen (PSMA) ligands are used to detect prostate cancer (PCa); most approaches utilize gallium PET and a few reports describe the role of SPECT/CT. [(99m)Tc]Tc-PSMA-T4 is a new radiopharmaceutical designed for the diagnosis of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ćwikła, Jarosław B., Roslan, Marek, Skoneczna, Iwona, Kempińska-Wróbel, Monika, Maurin, Michał, Rogowski, Wojciech, Janota, Barbara, Szarowicz, Anna, Garnuszek, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623387/
https://www.ncbi.nlm.nih.gov/pubmed/34832889
http://dx.doi.org/10.3390/ph14111107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623387/
https://www.ncbi.nlm.nih.gov/pubmed/34832889
http://dx.doi.org/10.3390/ph14111107

Ejemplares similares